Insider trade

Agilon Health (AGL)Director bought ~$50K

Silvana Battaglia, Director at Agilon Health, bought ~$50K of Agilon Health shares.

~$50K
Approx. value · 25K sh @ $2.01
66K
Holds after · shares reported
Traded
Dec 11, 2024
Filed
Dec 13, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 29, 2023InsiderCFO purchased ~$250K of AGL shares in the open market
  2. Nov 25, 2024InsiderDirector purchased ~$28K of AGL shares in the open market
  3. Dec 5, 2024InsiderDirector purchased ~$98K of AGL shares in the open market
  4. Dec 9, 2024InsiderDirector purchased ~$16K of AGL shares in the open market
  5. Dec 11, 2024 · this disclosureInsiderDirector purchased ~$50K of AGL shares in the open market

What came next

  1. Dec 13, 2024InsiderDirector purchased ~$55K of AGL shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Agilon Health

For Agilon Health, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AGL page.

Other recent filings by Silvana Battaglia, Director

The full history of Silvana Battaglia, Director is on the profile page.

How this filing works

Other disclosures at Agilon Health

Everything OQRO holds on this company is on its AGL page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data